Biopol Chemicals IPO Listing at 3.00% Premium at ₹111.00 Per Share 

Biopol Chemicals IPO Listing Today: The Biopol Chemicals IPO was subscribed 22.33 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 21.05 times, and non-institutional investors (NIIs) received 24.49 times. The retail quota of the issue was subscribed to 33.25%. Before delving deeper into the topic, go through the details of the Biopol Chemicals IPO.

Biopol Chemicals IPO

It is a book-building issue IPO of ₹31.26 crore, comprising an entirely fresh issue of 0.29 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 13th February 2026. The Biopol Chemicals IPO date is scheduled from 6th January 2026 to 10th January 2026. The face value of Biopol Chemicals shares stands at ₹10 per share, and the IPO Issue price band is set at ₹102 to ₹108 per share

Biopol Chemicals Listing

On the NSE & SME platforms, Biopol Chemicals shares are listed at ₹111.00 per share, reflecting a 3.00% premium over the issue price of ₹108 per share. 

About the Biopol Chemicals IPO

Biopol Chemicals Limited was incorporated in the year 2023. The company is engaged in the manufacture and trading of speciality chemicals comprising silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s portfolio of products comprises 66 products, comprising 40 silicone-based products, 5 emulsifier-based products, 15 biochemical-based products, and 6 polyelectrolyte-based products. The products find their applications in the textile, home care, agriculture, and industrial chemicals industries. The company follows a B2B business model wherein the company sells its products to institutional clients and not directly to retail end-consumers. The company operates the 4 establishments located in West Bengal and Gujarat, comprising their manufacturing unit, warehouse, and corporate office in West Bengal, and the registered office located in West Bengal.

Biopol Chemicals Limited Financials

The company’s financial analysis is essential before applying for the Biopol Chemicals IPO. See the table for Biopol Chemicals Limited’s financials. 

Explanation

Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.

Recent Articles

Best 1-Year SIP Plans 2026: Top Monthly SIP Plans in India

Fractal Industries IPO Review 2026: GMP Rises Rises 2.31%, Key Investor Insights

Marushika Technology IPO Day 1: Subscription at 0.08x, GMP Flat | Live Updates

PAN HR Solutions IPO Listing Preview: What to Expect Now?

Biopol Chemicals IPO Listing Preview: What to Expect Now?

Aye Finance IPO Listing Preview: What to Expect Now?

Fractal Analytics IPO Listing Preview: What to Expect Now?